Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ABBOTT LABORATORIES Hits Forecasted Price Target with 12.49% Profit

January 23, 2025
QuantWave, the automated forecasting platform, successfully predicted a long signal for ABBOTT LABORATORIES on July 25, 2023, when the stock price was at 108.54 $. The platform forecasted that the price would increase, and on January 23, 2025, the target of 122.1 $ was reached, resulting in a profit of 12.49%.

This achievement demonstrates the accuracy and reliability of QuantWave's analytics in predicting stock movements. The successful forecast for ABBOTT LABORATORIES underscores the platform's ability to provide valuable insights for investors looking to capitalize on market opportunities.

Factors contributing to the stock movement may include the company's financial performance, market dynamics, industry trends, and macroeconomic conditions. By analyzing these variables, QuantWave was able to generate a precise forecast for ABBOTT LABORATORIES, enabling users to make informed investment decisions.

QuantWave offers users access to predictions for a wide range of stocks, presenting opportunities for potential profits. For investors interested in exploring the platform further, QuantSchool provides educational resources on the professional investment framework behind QuantWave. By understanding the key principles of the forecasting system, investors can enhance their investment strategies and maximize returns.
If you want to leave a comment, then you need Login or Register





Other data for ABT

Related data

ABTAugust 9, 2025Abbott Laboratories NYSE:ABT Earnings Are Of Questionable Quality  ~1 min.

Abbott Laboratories recently reported their second quarter 2025 earnings, with EPS exceeding expectations....


ABTJune 5, 2025Abbott Laboratories ABT is Attracting Investor Attention: Here is What You Should Know  ~1 min.

Abbott Laboratories (ABT) has been making waves in the healthcare sector, attracting attention from investors around the globe....


ABTMarch 18, 2025Abbott Laboratories Continues to Drive Growth in the Healthcare Sector  ~2 min.

Abbott Laboratories (ABT) has emerged as a top player in the healthcare industry, making it an attractive stock for long-term investors....


ABTMarch 17, 2025Abbott Laboratories: A Leader in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) is a renowned healthcare company that has caught the attention of investors and industry experts alike....


ABTMarch 16, 2025Abbott Laboratories: Breaking New Ground in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making waves in the healthcare industry with its groundbreaking innovations....


ABTMarch 15, 2025Abbott Laboratories: A Healthcare Stock With Long-Term Investment Potential  ~2 min.

Abbott Laboratories (NYSE:ABT) is a renowned healthcare company that has been delivering groundbreaking medical technologies and products for decades....


ABTFebruary 26, 2025Abbott Laboratories Continues to Deliver Strong Earnings Growth  ~2 min.

Abbott Laboratories, a leading global healthcare company, has reported steady growth in earnings over the past five years....


ABTFebruary 22, 2025Abbott Laboratories: A Rising Star in the Pharmaceutical Industry  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making significant progress in the pharmaceutical industry, positioning itself as one of the best drug stocks to buy now....


ABTFebruary 21, 2025Abbott Laboratories NYSE:ABT: A Leading Drug Stock with Promising Future  ~1 min.

Abbott Laboratories, a renowned pharmaceutical company, has emerged as one of the best drug stocks to invest in....


ABTFebruary 21, 2025ABBOTT LABORATORIES Stock Hits Price Target with 16.11% Profit: QuantWave Forecast Success  ~2 min.

On December 2, 2024, QuantWave, the automated forecasting platform, issued a long signal for ABBOTT LABORATORIES stock when it was trading at 115.66 $....


ABTFebruary 20, 2025ABBOTT LABORATORIES Stock Hits Price Target Forecast with 15.12% Profit, QuantWave Analysis Shows Strong Predictive Power  ~2 min.

ABBOTT LABORATORIES (NYSE: ABT) investors reaped substantial gains as the stock price hit the forecasted target of 132.56 $ on February 20, 2025, resulting in a profit of 15.12%....


ABTFebruary 5, 2025ABBOTT LABORATORIES Hits Price Target Forecast with a 13.86% Profit, Validating QuantWave's Analytics  ~1 min.

Following a forecast signal date of November 8, 2024, with a price of $114.93 and a predicted long direction, ABBOTT LABORATORIES stock has successfully reached the target price of $130....


ABTJanuary 10, 2024ABBOTT LABORATORIES Hits QuantWave Forecast Target with 9.63% Profit  ~1 min.

On December 5, 2023, QuantWave, the automated forecasting platform, issued a long signal for ABBOTT LABORATORIES stock, which was trading at $100.85 at the time....


ABTFebruary 5, 2025ABBOTT LABORATORIES Stock Hits Price Target Forecast with 14.01% Profit: QuantWave Analysis  ~1 min.

Abbott Laboratories' stock recently achieved the price target forecast set by QuantWave, resulting in a profit of 14.01% for investors. The forecast signal date was November 12, 2024, with a price of 114.78$....


ABTJanuary 27, 2025ABBOTT LABORATORIES Hits Price Target Forecast with 12.05% Profit  ~1 min.

On October 22, 2024, QuantWave issued a price target forecast signal for ABBOTT LABORATORIES with a price of $114.47 and a predicted direction of long....